top of page
Incubate bio’s platform, ALaSCA, untangles the pivots and redundancies within biological pathways
Traditional machine learning and artificial intelligence methods are limited in what they can do. Causal inference is required.
Our technology (ALaSCA) applies causal inference and machine learning to uncover drivers in biological mechanisms (such as protein networks), using multi-omics and phenotypic (and clinical) data. ALaSCA has been validated using a diabetes Type 1 case study.
We offer ALaSCA to life sciences companies (drug discovery, medtech, bioactives research, agri-tech etc) as part of our biology-as-a-service.
Applying ALaSCA to simple organisms and studying ageing mechanisms, we have found a new way forward to unlock novel targets in Alzheimer's Disease.
Simple Organism Systems
Shared biological processes
Unlocked cellular dynamics
Is Causal Analysis the solution to AI in Drug Discovery?
Hosted by Tony Sedgwick, CoffeeBuddies, Feb 8 2023
bottom of page